Published : 27 Aug 2023
A US based Innovator has appointed Aagami for evaluation of his Intellectual Property of two patent families and the underlying technology.
The objective of the client’s invention is to provide treatment of migraine and other indications such as pain, fever, dysmenorrhea, acute migraine, menstrual or pre-menstrual migraine using active aspirin derivative and COX-2 inhibitor.
The technology is segmented into two patent families.
Aagami in association with its IP specialist (Among Global Top 10) partner will execute and deliver the project. This shall include:
Once this is delivered, Aagami will also support client getting a valuation done to prepare for licensing / acquisition.
Eventually, at a later stage, client would also engage Aagami for Out-licensing or selling the IP to a worthy and relevant partner/buyer who can realize the true potential of the IP for profits as well as service to the society.
If you would like to know more about this opportunity, please contact us.